When John Laszlo joined the Acute Leukemia Service at NCI in 1956, the field of oncology was nascent—and the cure for childhood leukemia seemed beyond reach.
Fifteen years ago, after the death of his favorite uncle, Steven Rosen committed his grief to paper.
A mainstay of cancer treatment, doxorubicin is used as a standalone agent or in combination therapies, on-label and off, in at least 14 cancer types, including breast cancer, non-small cell lung cancer, and Wilms tumor.
St. Jude’s Path to a Bright Future, an HPV awareness and vaccination campaign with nearly 160 partners, is aimed at reducing that disease burden by targeting children in a crucial age range.
The standard of care in HPV vaccination may soon change if a one-dose regimen is found to be just as efficacious as two or three doses—once a large trial that NCI is conducting in Costa Rica, in young women ages 12 to 16, is ready to report final results in a few years. “We’ve done […]
Scientists used to dismiss the notion that the Y chromosome plays a role in cancer.
On June 29, the United States Supreme Court issued a ruling that reverses 45 years of legal precedent in admissions at institutions of higher learning, striking a death blow to affirmative action.
The Sunderland Foundation has given The University of Kansas Cancer Center a $100 million gift to construct a cancer center building.
The University of Florida Health Cancer Center has received NCI Cancer Center designation.
VCU Massey Cancer Center can now add the word “Comprehensive” to its name.
